Showing results (491-500 of 1,813) with videos related to

Sort By:
Pageof 182
Transplantation and Cellular Therapy|August 23, 2025
Treatment of diffuse large B-cell lymphoma progressing or relapsing after chimeric antigen receptor T-cell therapyMohamed A Kharfan-Dabaja, Tea Reljic, Razan Mohty, et al.
Transplantation and Cellular Therapy|August 30, 2025
Allogeneic hematopoietic stem cell transplantation for older patients with adult T-cell leukemia/lymphoma: A nationwide retrospective studyHikaru Sakamoto, Yasushi Sawayama, Shigeo Fuji, et al.
Transplantation and Cellular Therapy|August 30, 2025
Dupilumab for the treatment of cutaneous graft-versus-host disease: a systematic review and individual patient data meta-analysisFilippo Consonni, Linda Zollo, Giuseppina Calise, et al.
Transplantation and Cellular Therapy|May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular TherapyCorrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.
Transplantation and Cellular Therapy|May 9, 2021
Safety and Efficacy of Consolidation Therapy with Ipilimumab Plus Nivolumab after Autologous Stem Cell TransplantationAlan P Skarbnik, Michele L Donato, Rena Feinman, et al.
Transplantation and Cellular Therapy|May 9, 2021
Haploidentical Peripheral Stem Cell Transplantation for Young Patients with Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide and MethotrexateKaitai Yang, Susu Gong, Tiebin Jiang, et al.
Transplantation and Cellular Therapy|May 9, 2021
Eltrombopag for Post-Transplantation Thrombocytopenia: Results of Phase II Randomized, Double-Blind, Placebo-Controlled TrialSairah Ahmed, Qaiser Bashir, Roland Bassett, et al.
Transplantation and Cellular Therapy|August 9, 2021
Prognostic Impact of Pretransplantation Quality of Life and Its Post-Transplantation Longitudinal Change after Allogeneic Hematopoietic Cell Transplantation: A Prospective Study That Administered the Short-Form Health Survey (SF-12) and EuroQol 5Saiko Kurosawa, Takuhiro Yamaguchi, Ayako Mori, et al.
Transplantation and Cellular Therapy|May 21, 2021
Moderate to Severe Marrow Fibrosis As a More Advanced Risk Factor for MDS and MDS-AML Patients With Excess of Blasts Receiving Allogeneic Hematopoietic Stem Cell TransplantationJiali Wang, Qianqian Wang, Haixiao Zhang, et al.
Transplantation and Cellular Therapy|August 11, 2021
Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host DiseaseDana A Schaar, Filip Pirsl, Noa Holtzman, et al.
Pageof 182